Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.8174
-0.0203 (-2.42%)
At close: Apr 7, 2026, 4:00 PM EDT
0.8600
+0.0426 (5.21%)
After-hours: Apr 7, 2026, 7:48 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $73.04 million as of April 7, 2026. Its market cap has increased by 176.20% in one year.
Market Cap
73.04M
Enterprise Value
36.87M
1-Year Change
176.20%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $73.04M, a decrease of -71.52%. That is a compound annual growth rate of -24.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 74.85M | -37.19% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 83.04M |
| NeurAxis | 81.11M |
| Fortress Biotech | 80.70M |
| MAIA Biotechnology | 80.69M |
| Champions Oncology | 80.13M |
| Grace Therapeutics | 79.38M |
| Gain Therapeutics | 78.15M |
| Adicet Bio | 75.14M |